| n = 548 |
---|---|
Demographics | Â |
  Age, mean (SD) | 67 (12) |
  Male, n (%) | 345 (63.0) |
Medical history, n (%) | Â |
  Hypertension | 406 (74.1) |
  Diabetes mellitus | 177 (32.3) |
  Hyperlipidaemia | 303 (55.3) |
  Atrial fibrillation | 169 (30.8) |
  Congestive heart failure | 37 (6.8) |
  Prior stroke/TIA | 116 (21.2) |
  Current smoking | 183 (33.4) |
  Antiplatelets | 129 (23.5) |
  Warfarin | 9 (1.6) |
Clinical data | Â |
  Baseline NIHSS score, median (IQR) | 13 (8–20) |
  Body weight, mean (SD), kg | 65 (13) |
  Systolic blood pressure, mean (SD), mm Hg | 161 (30) |
  Glucose, mean (SD), mmol/L | 8.49 (3.72) |
  Platelet count, mean (SD), ×109/L | 215 (70) |
  Actual tPA dose, median (IQR), mg/kg | 0.86 (0.75–0.91) |
  OTT, median (IQR), min | 125 (100–155) |
OCSP classification, n (%) | Â |
  TACI | 207 (37.8) |
  PACI | 162 (29.6) |
  POCI | 48 (8.8) |
  LACI | 111 (20.3) |
  Uncertain | 20 (3.6) |